1-4 of 4
Barry L. Gause
Close
Sort by
Journal Articles

A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma

Brief Report
Sattva S. Neelapu, Barry L. Gause, Linda Harvey, Seung-Tae Lee, Andrea Robin Frye, Jessie Horton, Richard J. Robb, Mircea C. Popescu, Larry W. Kwak
Journal: Blood
Blood (2007) 109 (12): 5160–5163.
https://doi.org/10.1182/blood-2006-12-063594
Published: 2007
Journal Articles

Human Autologous Tumor-Specific T-Cell Responses Induced by Liposome Encapsulated Lymphoma Membrane Proteins.

Sattva S. Neelapu, M.D., Barry L. Gause, M.D., Linda Harvey, Andrea R. Frye, R.N., Jessie Horton, R.N., Richard J. Robb, Ph.D., Mircea C. Popescu, M.D., Ph.D., Larry W. Kwak, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 749.
https://doi.org/10.1182/blood.V104.11.749.749
Published: 2004
Journal Articles

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma

Clinical Trials & Observations
John E. Janik, Langdon L. Miller, Edward L. Korn, Diane Stevens, Brendan D. Curti, John W. Smith, II, Mario Sznol, Kevin C. Conlon, William Sharfman, Walter J. Urba, Barry L. Gause, Dan L. Longo
Journal: Blood
Blood (2001) 97 (7): 1942–1946.
https://doi.org/10.1182/blood.V97.7.1942
Published: 2001
Journal Articles

Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin

Langdon L. Miller, Edward L. Korn, Diane S. Stevens, John E. Janik, Barry L. Gause, William C. Kopp, Jon T. Holmlund, Brendan D. Curti, Mario Sznol, John W. Smith, II, Walter J. Urba, Sarah E. Donegan, Thelma M. Watson, Dan L. Longo
Journal: Blood
Blood (1999) 93 (10): 3250–3258.
https://doi.org/10.1182/blood.V93.10.3250.410k35_3250_3258
Published: 1999